Insider · CIK 0001663219

Giles Mark T

Reports to the SEC for 1 company · CHARLOTTESVILLE, VA

sec.gov

Transactions

Companies

Filings

CIK

0001663219

Forms 4 and 5

Insider transactions

20 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-07-01	CRVOCervoMed Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+83.3K sh	—	—	83,300
2020-06-17	CRVOCervoMed Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+61.3K sh	—	—	61,300
2019-06-13	CRVOCervoMed Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+19.2K sh	—	—	19,200
2019-06-13	CRVOCervoMed Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+13.1K sh	—	—	13,100
2018-06-14	CRVOCervoMed Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2018-01-02	CRVOCervoMed Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2017-06-15	CRVOCervoMed Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+23.9K sh	—	—	23,900
2016-12-28	CRVOCervoMed Inc.P Purchase	Director	PPurchase	+291K sh	—	—	802,689
2016-12-27	CRVOCervoMed Inc.J Other	Director	JOther	−291K sh	—	—	0
2016-12-15	CRVOCervoMed Inc.P Purchase	Director	PPurchase	+512K sh	—	—	512,109
2016-12-14	CRVOCervoMed Inc.J Other	Director	JOther	−339K sh	—	—	290,580
2016-12-08	CRVOCervoMed Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14K sh	—	—	14,000
2016-07-21	CRVOCervoMed Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+58.5K sh	—	—	58,473
2016-01-08	CRVOCervoMed Inc.A Award	Director	AAward	+44.1K sh	—	—	44,069
2016-01-08	CRVOCervoMed Inc.A Award	Director	AAward	+6.3M sh	—	—	6,296,346
2016-01-08	CRVOCervoMed Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+98.6K sh	—	—	98,621
2016-01-08	CRVOCervoMed Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+91.3K sh	—	—	91,316
2016-01-08	CRVOCervoMed Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+183K sh	—	—	182,632
2016-01-08	CRVOCervoMed Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+183K sh	—	—	182,632
2016-01-08	CRVOCervoMed Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+365K sh	—	—	365,265

Recent filings

Accepted (ET)
Jul 64
Giles Mark T0001437749-21-016508
SEC(opens sec.gov)
Jun 184
Giles Mark T0001437749-20-013421
SEC(opens sec.gov)
Aug 64/A
Giles Mark T0001437749-19-015540
SEC(opens sec.gov)
Jul 194
Giles Mark T0001437749-19-014277
SEC(opens sec.gov)
Jun 184
Giles Mark T0001437749-18-012014
SEC(opens sec.gov)
Jan 44
Giles Mark T0001437749-18-000256
SEC(opens sec.gov)
Jun 164
Diffusion Pharmaceuticals Inc.0001437749-17-011437
SEC(opens sec.gov)
Dec 284
Diffusion Pharmaceuticals Inc.0001437749-16-043856
SEC(opens sec.gov)
Dec 164
Diffusion Pharmaceuticals Inc.0001437749-16-043483
SEC(opens sec.gov)
Dec 134
Diffusion Pharmaceuticals Inc.0001437749-16-043295
SEC(opens sec.gov)
Jul 254
Diffusion Pharmaceuticals Inc.0001437749-16-035627
SEC(opens sec.gov)
Jan 124
RestorGenex Corp0001437749-16-023550
SEC(opens sec.gov)

Companies

CervoMed Inc.DirectorCRVO

Address

2020 AVON COURT, SUITE 4

CHARLOTTESVILLE, VA, 22902